PDS Biotechnology Stock Forward View - Simple Regression
| EU6 Stock | EUR 0.55 0.02 3.51% |
PDS Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of PDS Biotechnology's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 20th of February 2026, the RSI of PDS Biotechnology's share price is approaching 35 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling PDS Biotechnology, making its price go up or down. Momentum 35
Sell Extended
Oversold | Overbought |
Wall Street Target Price 19.71 |
Using PDS Biotechnology hype-based prediction, you can estimate the value of PDS Biotechnology Corp from the perspective of PDS Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of PDS Biotechnology Corp on the next trading day is expected to be 0.66 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.60. PDS Biotechnology after-hype prediction price | EUR 0.58 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
PDS |
PDS Biotechnology Additional Predictive Modules
Most predictive techniques to examine PDS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PDS using various technical indicators. When you analyze PDS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
PDS Biotechnology Simple Regression Price Forecast For the 21st of February
Given 90 days horizon, the Simple Regression forecasted value of PDS Biotechnology Corp on the next trading day is expected to be 0.66 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.60.Please note that although there have been many attempts to predict PDS Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that PDS Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
PDS Biotechnology Stock Forecast Pattern
| Backtest PDS Biotechnology | PDS Biotechnology Price Prediction | Research Analysis |
PDS Biotechnology Forecasted Value
In the context of forecasting PDS Biotechnology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. PDS Biotechnology's downside and upside margins for the forecasting period are 0.01 and 6.26, respectively. We have considered PDS Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of PDS Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent PDS Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.2644 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0755 |
| MAPE | Mean absolute percentage error | 0.1076 |
| SAE | Sum of the absolute errors | 4.6049 |
Predictive Modules for PDS Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PDS Biotechnology Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.PDS Biotechnology After-Hype Price Density Analysis
As far as predicting the price of PDS Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PDS Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of PDS Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
PDS Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting PDS Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PDS Biotechnology's historical news coverage. PDS Biotechnology's after-hype downside and upside margins for the prediction period are 0.03 and 6.18, respectively. We have considered PDS Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
PDS Biotechnology is out of control at this time. Analysis and calculation of next after-hype price of PDS Biotechnology Corp is based on 3 months time horizon.
PDS Biotechnology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as PDS Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PDS Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PDS Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 5.60 | 0.00 | 0.05 | 4 Events / Month | 2 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.55 | 0.58 | 0.00 |
|
PDS Biotechnology Hype Timeline
PDS Biotechnology Corp is currently traded for 0.55on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.05. PDS is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -0.04%. %. The volatility of related hype on PDS Biotechnology is about 445.51%, with the expected price after the next announcement by competition of 0.60. About 15.0% of the company shares are held by institutions such as insurance companies. The book value of PDS Biotechnology was currently reported as 0.17. The company recorded a loss per share of 0.68. PDS Biotechnology Corp had not issued any dividends in recent years. The entity had 1:20 split on the 18th of March 2019. Assuming the 90 days horizon the next estimated press release will be in about 4 days. Check out Historical Fundamental Analysis of PDS Biotechnology to cross-verify your projections.PDS Biotechnology Related Hype Analysis
Having access to credible news sources related to PDS Biotechnology's direct competition is more important than ever and may enhance your ability to predict PDS Biotechnology's future price movements. Getting to know how PDS Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PDS Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SSU | Samsung Electronics Co | 10.00 | 2 per month | 2.24 | 0.25 | 7.66 | (4.89) | 15.03 | |
| 2WGA | WOORI FIN GRP | 2.80 | 3 per month | 2.06 | 0.16 | 5.88 | (2.92) | 19.36 | |
| PKX | POSCO Holdings | (1.00) | 7 per month | 2.11 | 0.08 | 4.76 | (4.00) | 20.00 | |
| TOMA | Toyota Motor | 0.50 | 4 per month | 1.91 | 0.1 | 2.84 | (3.18) | 8.41 | |
| 5EE | MEBUKI FINANCIAL GROUP | 0.05 | 3 per month | 1.20 | 0.22 | 3.60 | (2.59) | 7.39 | |
| 4FK | Fukuoka Financial Group | (0.40) | 4 per month | 0.91 | 0.29 | 4.44 | (2.00) | 12.04 | |
| LGLG | LG Electronics | 0.60 | 5 per month | 3.77 | 0.02 | 8.55 | (6.62) | 17.99 | |
| C6TB | CHINA BANK ADR20 | 0.00 | 0 per month | 0.00 | (0.04) | 1.83 | (3.51) | 15.99 | |
| ICK | Industrial and Commercial | 0.02 | 2 per month | 3.25 | (0) | 2.99 | (2.90) | 23.71 | |
| ICKB | INDCOMMBK CHINA ADR20 | 0.00 | 1 per month | 0.00 | (0.06) | 3.01 | (2.84) | 10.33 |
Other Forecasting Options for PDS Biotechnology
For every potential investor in PDS, whether a beginner or expert, PDS Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. PDS Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in PDS. Basic forecasting techniques help filter out the noise by identifying PDS Biotechnology's price trends.PDS Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PDS Biotechnology stock to make a market-neutral strategy. Peer analysis of PDS Biotechnology could also be used in its relative valuation, which is a method of valuing PDS Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
PDS Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how PDS Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PDS Biotechnology shares will generate the highest return on investment. By undertsting and applying PDS Biotechnology stock market strength indicators, traders can identify PDS Biotechnology Corp entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 0.55 | |||
| Day Typical Price | 0.55 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) | |||
| Relative Strength Index | 35.86 |
PDS Biotechnology Risk Indicators
The analysis of PDS Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in PDS Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pds stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.06 | |||
| Standard Deviation | 5.72 | |||
| Variance | 32.77 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for PDS Biotechnology
The number of cover stories for PDS Biotechnology depends on current market conditions and PDS Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PDS Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PDS Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Historical Fundamental Analysis of PDS Biotechnology to cross-verify your projections. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.